دواعي استعمال تيكليفا بلس 0.004%/0.5% قطرة للعين 2.5مل

Travoprost 0.004% + timolol 0.5% eye drops, 2.5 ml bottle (EVA Pharma, Egypt), antiglaucoma.

• Decrease of IOP in adults with open-angle glaucoma or ocular hypertension insufficiently responsive to topical beta blockers or prostaglandin analogues.الفئة: Adultselectronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)

• Most frequent treatment-related adverse reaction in clinical studies: ocular hyperaemia (12.0%).نشرة دولية لنفس التركيبة · electronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)

• Hypersensitivity to actives/excipients or other beta blockers; reactive airway disease incl. asthma or history of asthma, severe COPD; sinus bradycardia, sick sinus syndrome, sino-atrial block, 2nd/3rd-degree AV block not controlled with pacemaker; overt cardiac failure, cardiogenic shock; severe allergic rhinitis and corneal dystrophies.نشرة دولية لنفس التركيبة · electronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)

• Travoprost and timolol are absorbed systemically; beta-blocker-type cardiovascular, pulmonary and other systemic adverse reactions may occur.نشرة دولية لنفس التركيبة · electronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)

• Travoprost has harmful pharmacological effects on pregnancy and/or the foetus/newborn; timolol should not be used in pregnancy unless clearly necessary.نشرة دولية لنفس التركيبة · electronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)
• Unknown whether travoprost is excreted in human milk (animal milk excretion shown); timolol is excreted in breast milk with potential for serious adverse reactions in the infant.نشرة دولية لنفس التركيبة · electronic medicines compendium (emc, medicines.org.uk; MHRA-authorised)

• ترافوبروست: Prostaglandin F2-alpha analogue / FP receptor agonist that lowers intraocular pressure (directory pharmacology summary).